Nicotine, Smoking and the Pharmacotherapy of Ulcerative Colitis
| dc.contributor.advisor | Pórszász, Róbert | |
| dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.contributor.author | Boros, Kata | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Drimba, László | |
| dc.contributor.opponent | Szentmiklósi, József András | |
| dc.contributor.opponentdept | Kenézy Kórház Központi Aneszteziológiai és Intenzív Terápiás Osztály | hu_HU |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.date.accessioned | 2019-01-30T11:09:35Z | |
| dc.date.available | 2019-01-30T11:09:35Z | |
| dc.date.created | 2018 | |
| dc.description.abstract | MD Thesis elucidating the current conventional pharmacotherapeutic drugs and protocols for ulcerative colitis disease, with a special focus on the role of smoking and its beneficial effects on clinical symptomatology. Inspired by these findings, investigations into whether nicotine in its various therapeutic formulations could be an efficacious addition into the pharmacologic treatment arsenal for disease management and remission induction in ulcerative colitis is explored. | hu_HU |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 34 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/263403 | |
| dc.language.iso | en | hu_HU |
| dc.subject | Ulcerative Colitis | hu_HU |
| dc.subject | Nicotine | hu_HU |
| dc.subject | Smoking | hu_HU |
| dc.subject | Pharmacology | hu_HU |
| dc.subject | Treatment | hu_HU |
| dc.subject.dspace | DEENK Témalista::Orvostudomány | hu_HU |
| dc.title | Nicotine, Smoking and the Pharmacotherapy of Ulcerative Colitis | hu_HU |